SciSparc (SPRC) Invested Capital (2018 - 2025)
SciSparc (SPRC) posted Invested Capital of $1.4 million for Q4 2025, up 695.6% sequentially from $182000.0 in Q2 2025, and down 71.58% YoY from $5.1 million in Q4 2024.
SciSparc (SPRC) Invested Capital (2018 - 2025) Analysis & Trends
SciSparc has reported Invested Capital for 5 years, with the latest figure at $1.4 million in Q4 2025.
- Quarterly Invested Capital fell 71.58% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.7 million (up 31.99% YoY) and the FY2025 annual result came in at $1.4 million, down 71.58% from the prior year.
- Invested Capital grew to $1.4 million in Q4 2025 per SPRC's latest filing, from $182000.0 in the prior quarter.
- Over five years, Invested Capital peaked at $5.1 million in Q4 2024 and troughed at $182000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | 356,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.45 Mn |
| Jun 30, 2025 | 182,000.00 |
| Dec 31, 2024 | 5.10 Mn |
| Dec 31, 2020 | 188,000.00 |
| Jun 30, 2020 | 61,000.00 |
| Jun 30, 2019 | 993,000.00 |
| Dec 31, 2018 | 779,000.00 |